In order to patent a new chemical compound, which is to be used for medical purposes, it is necessary to present already in the patent application the results of a research confirming its therapeutic effects.

In the latest issue of the magazine “The World of Pharmaceutical Industry” (“Świat Przemysłu Farmaceutycznego”) Barbara Milczarek, a patent attorney at Patpol, discussed the obligation of a sufficient disclosure of invention in the context of the application procedures.

We invite you to read the full article in polish.

A bunch of Italian entrepreneurs are still trying to register a trademark with the symbol of cannabis ? do such marks really incite consumers to use illegal substances?

New article on IP-Blog.pl by Nina Jankowska In my previous publications on IP Blog I Czytaj dalej

What comes next after obtaining trademark protection in Poland? – Article by Monika Zielińska for The Trademark Lawyer Magazine

In the latest Trademark Lawyer Magazine, Monika Zielińska, presents a handful of tips on what Czytaj dalej

Patpol with another Managing IP recommendation!

We are delighted to have been honored also this year in the international IP STARS Czytaj dalej